We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 6 start-ups with an aggregate funding of $263.4m. The average funding per company in this subset is $43.9m.
Last update to the database: Feb 18, 2025. See changelog.
2
Funding Rounds
$82.0m
Money raised
Novadip Biosciences is a biotechnology company developing regenerative medicines using stem cells.
2
Funding Rounds
$130.9m
Money raised
Precirix is a private, clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing novel radiopharmaceuticals, using camelid-derived single-domain antibodies (sdAb) labeled with radioisotopes.
1
Funding Rounds
$33.6m
Money raised
Confo Therapeutics' unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets.
1
Funding Rounds
$2.2m
Money raised
EsoBiotec is a vivo engineered cell therapies for cancer treatment founded in 2020.
1
Funding Rounds
$8.6m
Money raised
Santero Therapeutics is a novel antibiotics to combat antimocrobial resistante founded in 2021.
1
Funding Rounds
$6.1m
Money raised
DeuterOncology is a preclinical-stage biotech company developing cancer treatments founded in 2020.
Enter your email and get access to 71,000 + technology companies you can partner with.